The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer

The histone deacetylase inhibitor panobinostat as a radiosensitiser in bladder cancer

<p>Muscle invasive bladder cancer (MIBC) has a poor prognosis. Currently, therapy consists of radical radiotherapy or cystectomy with or without chemotherapy. The average age of patients with MIBC is high and older patients are less able to tolerate surgery or chemoradiation due to their impai...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	Groselj, B
Бусад зохиолчид:	Kiltie, A
Формат:	Дипломын ажил
Хэл сонгох:	English
Хэвлэсэн:	2014
Нөхцлүүд:	Oncology Biology

Ижил төстэй зүйлс

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
-н: Groselj, B, зэрэг
Хэвлэсэн: (2013)

Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression.
-н: Groselj, B, зэрэг
Хэвлэсэн: (2013)

Histone deacetylase inhibitors as radiosensitisers: Effects on DNA damage signalling and repair
-н: Groselj, B, зэрэг
Хэвлэсэн: (2013)

Histone deacetylase inhibitors as radiosensitisers: effects on DNA damage signalling and repair.
-н: Groselj, B, зэрэг
Хэвлэсэн: (2013)

Histone Deacetylases and Their Potential as Targets to Enhance Tumour Radiosensitisation
-н: Jennifer Antrobus, зэрэг
Хэвлэсэн: (2022-03-01)

The histone deacetylase inhibitor romidepsin spares normal tissues while acting as an effective radiosensitiser in bladder tumours in vivo
-н: Paillas, S, зэрэг
Хэвлэсэн: (2020)

Radiosensitisation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity
-н: Groselj, B, зэрэг
Хэвлэсэн: (2017)

Identification of novel strategies to radiosensitise tumour cells
-н: Anbalagan, S
Хэвлэсэн: (2014)

The histone deacetylase inhibitor LBH589 (panobinostat) modulates the crosstalk of lymphocytes with Hodgkin lymphoma cell lines.
-н: Jan M Klein, зэрэг
Хэвлэсэн: (2013-01-01)

Internalising radioimmunoconjugates to target KRas cancer cells for simultaneous radio-ligand therapy and radiosensitisation
-н: Lourenço, J
Хэвлэсэн: (2024)

The Combination of Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Delays KMT2A-Rearranged Leukemia Progression
-н: Lin Xiao, зэрэг
Хэвлэсэн: (2022-05-01)

The emerging role of histone deacetylase (HDAC) inhibitors in urological cancers.
-н: Sharma, N, зэрэг
Хэвлэсэн: (2013)

Histone deacetylase inhibitor panobinostat induces antitumor activity in epithelioid sarcoma and rhabdoid tumor by growth factor receptor modulation
-н: Anne Catherine Harttrampf, зэрэг
Хэвлэсэн: (2021-07-01)

Molecular Mechanism of the Cell Death Induced by the Histone Deacetylase Pan Inhibitor LBH589 (Panobinostat) in Wilms Tumor Cells.
-н: Tao Yan-Fang, зэрэг
Хэвлэсэн: (2015-01-01)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
-н: Monica Phimmachanh, зэрэг
Хэвлэсэн: (2020-10-01)

The HDAC Inhibitor Panobinostat Promotes Expression of Delta 133p53 Variants in TP53 Wild-type Bladder Cancer Cells
-н: Groselj, B, зэрэг
Хэвлэсэн: (2012)

Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma
-н: AGM Mostofa, зэрэг
Хэвлэсэн: (2021-12-01)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
-н: Masumeh Sanaei, зэрэг
Хэвлэсэн: (2019-01-01)

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis.
-н: Martina Korfei, зэрэг
Хэвлэсэн: (2018-01-01)

Acetylation and Histone Deacetylase Inhibitors in Cancer
-н: Madeleine S. Q. Kortenhorst, зэрэг
Хэвлэсэн: (2006-01-01)

Histone Deacetylases and their Inhibitors in Cancer Epigenetics
-н: Kelly N. Hassell
Хэвлэсэн: (2019-11-01)

The Pan-Deacetylase Inhibitor Panobinostat Inhibits Growth of Hepatocellular Carcinoma Models by Alternative Pathways of Apoptosis
-н: Pietro Di Fazio, зэрэг
Хэвлэсэн: (2010-01-01)

Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
-н: Yukiko Hazama, зэрэг
Хэвлэсэн: (2022-01-01)

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy
-н: Guo Li, зэрэг
Хэвлэсэн: (2020-09-01)

HBI-8000, HUYABIO Lead Clinical Program, Is a Selective Histone Deacetylase Inhibitor With Therapeutic Benefits in Leukemia and in Solid Tumors
-н: Farbod Shojaei, зэрэг
Хэвлэсэн: (2022-01-01)

SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A
-н: Ruicai Gu, зэрэг
Хэвлэсэн: (2023-10-01)

Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines
-н: Zopf Steffen, зэрэг
Хэвлэсэн: (2012-09-01)

Fluid-electrolyte homeostasis requires histone deacetylase function
-н: Kelly A. Hyndman, зэрэг
Хэвлэсэн: (2020-08-01)

Characterisation of the histone acetyltransferase KAT7 as a novel target for radiosensitisation
-н: Bittner, M
Хэвлэсэн: (2017)

Potential of histone deacetylase inhibitors for the therapy of ovarian cancer
-н: Fengyi Guo, зэрэг
Хэвлэсэн: (2022-11-01)

Nanotechnology-Based Histone Deacetylase Inhibitors for Cancer Therapy
-н: Bin Tu, зэрэг
Хэвлэсэн: (2020-06-01)

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
-н: Danqi Chen, зэрэг
Хэвлэсэн: (2016-01-01)

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo
-н: Liebes Leonard, зэрэг
Хэвлэсэн: (2007-10-01)

Histone deacetylase inhibitors in multiple myeloma
-н: Sarah Deleu, зэрэг
Хэвлэсэн: (2009-06-01)

Clinical Toxicities of Histone Deacetylase Inhibitors
-н: Richard L. Piekarz, зэрэг
Хэвлэсэн: (2010-08-01)

The application of histone deacetylases inhibitors in glioblastoma
-н: Rui Chen, зэрэг
Хэвлэсэн: (2020-07-01)

Antidepressant Actions of Histone Deacetylase Inhibitors
-н: Haggarty, Stephen J., зэрэг
Хэвлэсэн: (2010)

Medicinal chemistry of histone deacetylase inhibitors
-н: Ružić Dušan, зэрэг
Хэвлэсэн: (2021-01-01)

Epigenetic drug screening defines a PRMT5 inhibitor–sensitive pancreatic cancer subtype
-н: Felix Orben, зэрэг
Хэвлэсэн: (2022-05-01)

Dietary fibre manipulation as a potential endogenous mechanism of radiosensitisation in bladder cancer
-н: Then, CK
Хэвлэсэн: (2022)